ATE35546T1 - 1-(substituiertes aryl)-dihydro-1h-pyrrolizin-3,5-(2h,6h>dione, verfahren zur herstellung dieser verbindungen und diese verbindungen enthaltende pharmazeutische zusammensetzung. - Google Patents
1-(substituiertes aryl)-dihydro-1h-pyrrolizin-3,5-(2h,6h>dione, verfahren zur herstellung dieser verbindungen und diese verbindungen enthaltende pharmazeutische zusammensetzung.Info
- Publication number
- ATE35546T1 ATE35546T1 AT85302948T AT85302948T ATE35546T1 AT E35546 T1 ATE35546 T1 AT E35546T1 AT 85302948 T AT85302948 T AT 85302948T AT 85302948 T AT85302948 T AT 85302948T AT E35546 T1 ATE35546 T1 AT E35546T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- pyrrolizine
- dihydro
- dione
- preparation
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 230000008569 process Effects 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 208000000044 Amnesia Diseases 0.000 abstract 1
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000006986 amnesia Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 230000019771 cognition Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/50—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
- C07C205/53—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/607,375 US4548947A (en) | 1984-05-07 | 1984-05-07 | 1-(Substituted-aryl)-dihydro-1H-pyrrolizine-3,5-[2H,6H-]diones and use for reversing amnesia |
| EP85302948A EP0164852B1 (de) | 1984-05-07 | 1985-04-26 | 1-(Substituiertes Aryl)-dihydro-1H-pyrrolizin-3,5-[2H,6H]dione, Verfahren zur Herstellung dieser Verbindungen und diese Verbindungen enthaltende pharmazeutische Zusammensetzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE35546T1 true ATE35546T1 (de) | 1988-07-15 |
Family
ID=24431993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85302948T ATE35546T1 (de) | 1984-05-07 | 1985-04-26 | 1-(substituiertes aryl)-dihydro-1h-pyrrolizin-3,5-(2h,6h>dione, verfahren zur herstellung dieser verbindungen und diese verbindungen enthaltende pharmazeutische zusammensetzung. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4548947A (de) |
| EP (1) | EP0164852B1 (de) |
| JP (1) | JPS60239487A (de) |
| AT (1) | ATE35546T1 (de) |
| AU (1) | AU564866B2 (de) |
| CA (1) | CA1252105A (de) |
| DE (1) | DE3563626D1 (de) |
| DK (1) | DK201585A (de) |
| ES (1) | ES8609326A1 (de) |
| ZA (1) | ZA852874B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663464A (en) * | 1986-03-21 | 1987-05-05 | Warner-Lambert Company | Process for the preparation of dihydro-1H-pyrrolizine-3,5-(2H,6H)-dione |
| CN107188808A (zh) * | 2017-05-22 | 2017-09-22 | 江苏斯威森生物医药工程研究中心有限公司 | 一种4‑氨基‑3‑苯基丁酸盐酸盐的合成方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1350582A (en) * | 1970-07-24 | 1974-04-18 | Ucb Sa | Cerivatives of 2-pyrrolidinone |
| DE2413935A1 (de) * | 1974-03-20 | 1975-10-16 | Schering Ag | 4-(polyalkoxy-phenyl)-2-pyrrolidone |
| US4372966A (en) * | 1980-09-15 | 1983-02-08 | Warner-Lambert Company | Use of dihydro-1H-pyrrolizine-3,5(2H,6H)-dione as a cognition activator |
| US4547519A (en) * | 1982-05-24 | 1985-10-15 | Warner-Lambert Company | Tetrahydro-3,5-dioxo-1H-pyrrolizine-7a(5H)-carboxylic acid and benzyl esters and amides thereof and their use in reversing amnesia |
-
1984
- 1984-05-07 US US06/607,375 patent/US4548947A/en not_active Expired - Fee Related
-
1985
- 1985-04-17 ZA ZA852874A patent/ZA852874B/xx unknown
- 1985-04-17 AU AU41340/85A patent/AU564866B2/en not_active Ceased
- 1985-04-23 CA CA000479812A patent/CA1252105A/en not_active Expired
- 1985-04-26 AT AT85302948T patent/ATE35546T1/de not_active IP Right Cessation
- 1985-04-26 DE DE8585302948T patent/DE3563626D1/de not_active Expired
- 1985-04-26 EP EP85302948A patent/EP0164852B1/de not_active Expired
- 1985-05-02 JP JP60093951A patent/JPS60239487A/ja active Pending
- 1985-05-03 ES ES542810A patent/ES8609326A1/es not_active Expired
- 1985-05-06 DK DK201585A patent/DK201585A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU564866B2 (en) | 1987-08-27 |
| US4548947A (en) | 1985-10-22 |
| DK201585A (da) | 1985-11-08 |
| DK201585D0 (da) | 1985-05-06 |
| EP0164852A1 (de) | 1985-12-18 |
| ES542810A0 (es) | 1986-07-16 |
| AU4134085A (en) | 1985-11-14 |
| CA1252105A (en) | 1989-04-04 |
| EP0164852B1 (de) | 1988-07-06 |
| JPS60239487A (ja) | 1985-11-28 |
| ZA852874B (en) | 1986-11-26 |
| ES8609326A1 (es) | 1986-07-16 |
| DE3563626D1 (en) | 1988-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9601598D0 (sv) | New process | |
| ES482134A1 (es) | Un procedimiento para preparar derivados de 1-(3-mercapto- 2-metilpropanoil)-prolil-aminoacido. | |
| DE69325662D1 (de) | Dopamin rezeptor subtyp liganden | |
| HUP9802937A2 (hu) | Benzo[g]kinolin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk | |
| FR2698873B1 (fr) | Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant. | |
| IL66341A (en) | Pyrrolidin-2-oxo-1-acetamides,their manufacture and pharmaceutical compositions containing them | |
| ATE51618T1 (de) | Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen. | |
| ATE161717T1 (de) | Antivirale mittel | |
| ATE18549T1 (de) | 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung. | |
| AU566770B2 (en) | Benyoylurea compositions | |
| MD1687F2 (en) | Arylthiocompounds, pharmaceutical composition, methods of bacterial and viral infections treatment | |
| AU564866B2 (en) | Pyrrolizine 3,5 - dione derivatives | |
| ES8203870A1 (es) | Procedimiento para preparar difenilbutil-1-acilpiperazinas | |
| DE59107813D1 (de) | Alkylaminoalkylamin- und -äther- Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| FR2707984B1 (fr) | Nouvelles pipérazines substituées, leur procédé de préparation et les compositions les contenant. | |
| TW372955B (en) | Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them | |
| ATE35538T1 (de) | (substituierte phenyl)-5-oxo-2pyrrolidinpropions|uren, verfahren zur herstellung dieser verbindungen und diese verbindungen enthaltende pharmazeutische zusammensetzungen. | |
| IL83164A (en) | Pharmaceutical compositions containing 2,3-dihydro-5-(hetero)aryl-imidazo(2,1-a)isoquinolines,some new such compounds and their preparation | |
| ATE19879T1 (de) | Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE34740T1 (de) | (bis(hydroxymethyl)methyl)-isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten. | |
| ATE30712T1 (de) | 4-hydroxy-alpha-aethyl-benzhydrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
| SE8701524D0 (sv) | Nya sulfonamider och deras framstellningsforfarande | |
| ES479804A1 (es) | Un procedimiento para la preparacion de derivados del acido amino-desoxi-clavulanico. | |
| ES8506700A1 (es) | Un procedimiento para preparar nuevas 5-aminometil-imidazol-1-il-1,3-dialquil-1h-pirazol-4-il-aroil-metanonas | |
| ATE22683T1 (de) | Substituiertes heterocyclylphenylsulphonyl und phosphonylamidine, verfahren zu deren herstellung und deren pharmazeutische anwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |